Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001641172-25-011721
Filing Date
2025-05-20
Accepted
2025-05-20 16:15:45
Documents
54
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q form10-q.htm   iXBRL 10-Q 596643
2 EX-31.1 ex31-1.htm EX-31.1 14931
3 EX-31.2 ex31-2.htm EX-31.2 15698
4 EX-32.1 ex32-1.htm EX-32.1 6700
5 EX-32.2 ex32-2.htm EX-32.2 7095
  Complete submission text file 0001641172-25-011721.txt   3602616

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE acut-20250331.xsd EX-101.SCH 28513
7 XBRL CALCULATION FILE acut-20250331_cal.xml EX-101.CAL 31584
8 XBRL DEFINITION FILE acut-20250331_def.xml EX-101.DEF 118376
9 XBRL LABEL FILE acut-20250331_lab.xml EX-101.LAB 248466
10 XBRL PRESENTATION FILE acut-20250331_pre.xml EX-101.PRE 199506
56 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 510735
Mailing Address 5 PENN PLAZA, 19TH FLOOR #1954 NEW YORK NY 10001
Business Address 5 PENN PLAZA, 19TH FLOOR #1954 NEW YORK NY 10001 442070661000
Accustem Sciences Inc. (Filer) CIK: 0001850767 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-56257 | Film No.: 25968986
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)